How asthma may affect your chances of pregnancy | WeForNews | Latest News, Blogs How asthma may affect your chances of pregnancy – WeForNews | Latest News, Blogs
Connect with us

Health

How asthma may affect your chances of pregnancy

Published

on

asthma

Sydney, Feb 16: Certain asthma medication, especially the “quick-acting” relievers, may affect women’s ability to conceive, warns a new study.

The study of more than 5,600 women showed that asthma patients who only use these short-acting asthma relievers take longer to become pregnant than other women.

But those who use long-acting asthma preventers conceive as quickly as other women, said the study published in the European Respiratory Journal.

While the short-acting asthma relievers provide quick relief of symptoms, long-acting asthma preventers are used to control the condition instead of getting quick relief.

“This study shows that women using short-acting asthma relievers take longer to get pregnant,” said lead researcher Luke Grzeskowiak from the University of Adelaide in Australia.

“On the other hand, continued use of long-acting asthma preventers to control asthma seems to protect fertility and reduce the time it takes women with asthma to become pregnant. This could lead to a reduction in the need for fertility treatments,” Grzeskowiak said.

The results provide reassurance for asthmatic women that using inhaled corticosteroids to prevent symptoms does not appear to reduce fertility, he said.

The researchers examined the data of women expecting their first babies in the early stages of pregnancy.

The participants were from Australia, New Zealand, Britain and Ireland.

The researchers found no difference in fertility between women using long-acting asthma treatments and women without asthma.

Women using short-acting reliever medication (known as beta-agonists) took 20 per cent longer to conceive on average.

They were also 30 per cent more likely to have taken more than a year to conceive.

“As well as affecting the lungs, asthma could cause inflammation elsewhere in the body, including the uterus. It could also affect the health of eggs in the ovaries,” Grzeskowiak said.

“Inhaled corticosteroids suppress the immune system, whereas short-acting asthma treatments do not alter immune function. In women who are only using relievers it’s possible that while their asthma symptoms may improve inflammation may still be present in the lungs and other organs in the body,” he added.

-IANS

Health

Sero Survey In Bhubaneswar: 50% Residents Develop Antibodies To Fight Coronavirus

Published

on

By

Coronavirus outbreak

Bhubaneswar: Half of the residents of Bhubaneswar have developed antibodies to fight novel Coronavirus. The statistics were revealed by ICMR – Regional Medical Research Centre (RMRC) Director, Dr Sanghamitra Pati today. Dr Pati said the survey was carried out between October 16 and 18 during which 1,400 samples were taken from all wards of Bhubaneswar Municipal Corporation (BMC).

As per the results, 50 per cent of Bhubaneswar’s population have been exposed to COVID-19, which means these many number of people now have the antibodies against the viral disease. “The results of the third sero survey corresponds to the status of infection, at least three weeks prior. So, there is much likelihood that exposure of people here to COVID-19 would have increased by now (October-end),” she said.

The good news is that 90 per cent of the people who are exposed to COVID-19 have very less or no symptoms. This implies that their immune system has been successful in fighting novel Coronavirus. Besides, 30 per cent of the people whose samples were collected have been tested through Rapid Antigen or RT-PCR, said Dr Pati.

Only around 2 per cent of Bhubaneswar’s population was found to be exposed to COVID-19 in the first sero survey. In the second survey in the last week of August, 5.1 per cent of the city’s population was exposed. Now, the result of the third sero survey is very encouraging, she said.

Continue Reading

Cities

‘Consider Masks As Vaccine Against Covid-19’: Satyendar Jain

Delhi has reported record jumps of over 5,000 Covid-19 cases for the past two days. It reported 5,673 cases on Wednesday and 5,739 on Thursday.

Published

on

By

child in mask

With Delhi reporting record jumps in Covid-19 cases for two straight days, Health Minister Satyendar Jain on Friday emphasised the importance of wearing face masks, saying people should consider them as a “vaccine” against the virus till the time one is available.

The spread of the virus can be stopped to a large extent if everyone wears a mask. Masks have more benefits than a lockdown, the minister said.

Delhi has reported record jumps of over 5,000 Covid-19 cases for the past two days. It reported 5,673 cases on Wednesday and 5,739 on Thursday.

“People should consider masks as a vaccine till there is one. The spread of the virus can be stopped to a large extent if everyone wears a mask,” Jain told PTI.

“A mask has more benefits than a lockdown,” he added.

The Delhi government has cited its new strategy involving aggressive contact tracing and testing as one of the reasons behind the sudden surge in the number of infections in the city.

The Union Health Ministry, however, has attributed the rise to social gatherings during festivities, deteriorating air quality, and increasing incidence of respiratory disorders.

The positivity rate in Delhi also jumped to 9.55 per cent on Thursday as the infection tally mounted to 3.75 lakh. The number of active cases in the city rose to 30,952 on Thursday from 29,378 the previous day.

Twenty-seven more fatalities were reported on Thursday, pushing the death toll in the national capital to 6,423.

Continue Reading

Health

Opportunity for India as Russia ready to produce Covid vax at foreign sites of partners

Putin also slammed the Western vaccines saying they were made from monkey and chimpanzee adenovirus.

Published

on

By

COVID-19 Vaccine

New Delhi: India has a huge opportunity to be the next big hub for vaccine production after Russia announced that it will manufacture Covid-19 vaccines at foreign sites with partners.

Amir Ullah Khan, economist at MCRHRDI of the Government of Telegana, and former senior advisor for Bill and Melinda Gates Foundation, said, “As Russia is keen to work with other countries, including India, this is a huge opportunity for us to be the next big hub for vaccine production. India has played an important role with the most prominent partnership of Dr. Reddy’s lab with the Russian Development Investment Fund. The lab will conduct clinical trials and provide Sputnik V for coronavirus in India.”

Russia has recently expressed the willingness to produce vaccines at foreign sites. It is very encouraging and a huge opportunity for India which is among the largest manufacturers of generic drugs and vaccines in the world. It is home to half a dozen major vaccine makers which are developing vaccines against the virus that causes Covid-19.

“With India’s increasing experience in manufacturing vaccines and crucial role in product innovation that is affordable, the country is foreseen as a growing vaccine hub. About 60 per cent of all vaccines worldwide are manufactured in India and it can be world’s door to vaccines,” said Gajendra Singh, a public health expert.

Russian President Vladimir Putin said on Thursday that Russia is ready to produce Covid-19 vaccines at the sites of foreign partners.

“Most importantly, we are ready to agree to produce this vaccine or these vaccines at the production sites of our foreign partners. They have this equipment, and I want to emphasise this, not to the detriment of vaccination in Russia itself, since we still have to purchase or develop this equipment, we are ready to work with our foreign partners,” Putin said.

“I just want to remind you that we are generally ready to work more closely with our colleagues in science than we have done so far. We know that many European countries have already signed contracts for the supply of vaccines from the UK,” Putin said.

Putin also slammed the Western vaccines saying they were made from monkey and chimpanzee adenovirus.

“Unfortunately, our colleagues there have experienced some malfunctions, they make their vaccine based on monkey and chimpanzee adenovirus, and our specialists at the Gamaleya Institute make it based on human adenovirus in order to deliver the necessary components to the cells in the human body. And it works effectively. Thank God, without glitches,” Putin said.

Putin added that mass vaccination will start by the end of the year.

“We do not have a single serious glitch in this area. Both the vaccines by Vector and the Gamaleya Institute work effectively. The question is how to mass produce it. The vaccine has already been delivered to all the regions of Russia. I hope that we will be able to start mass vaccination at the end of the year,” Putin said.

Continue Reading

Most Popular

Corona Virus (COVID-19) Live Data

COVID-19 affects different people in different ways. Most infected people will develop mild to moderate illness and recover without hospitalization.